Skip to main content

News

Press Release
12/28/2019
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also...
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also...
The U.S. Food and Drug...
12/28/2019
EP Lab Digest
Press Release
12/28/2019
ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), announced several additions to its leadership team. Joining are...
ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), announced several additions to its leadership team. Joining are...
ControlRad, Inc., a privately...
12/28/2019
EP Lab Digest
Press Release
12/28/2019
CardiaCare, a startup developing wearable therapeutic devices for treating and monitoring AFib, announced that it has been named the First Prize winner of the 2019 Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel...
CardiaCare, a startup developing wearable therapeutic devices for treating and monitoring AFib, announced that it has been named the First Prize winner of the 2019 Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel...
CardiaCare, a startup developing...
12/28/2019
EP Lab Digest
Press Release
12/20/2019
Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced that its focal Pulsed Field (PF) ablation technology, also known as Irreversible Electroporation (IRE), has been...
Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced that its focal Pulsed Field (PF) ablation technology, also known as Irreversible Electroporation (IRE), has been...
Affera, Inc., a private medical...
12/20/2019
EP Lab Digest
Press Release
12/18/2019
Innovative Health, Inc. announced that it has received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s inception in 2016. Single-use device (SUD) reprocessing is an FDA regulated and sanctioned...
Innovative Health, Inc. announced that it has received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s inception in 2016. Single-use device (SUD) reprocessing is an FDA regulated and sanctioned...
Innovative Health, Inc....
12/18/2019
EP Lab Digest
Press Release
12/05/2019
Itamar Medical Ltd., a company that develops, manufactures, and markets non-invasive ambulatory diagnostic medical devices for sleep apnea and offers Total Sleep Solution using a cloud-based digital health platform, and SoClean Inc., a...
Itamar Medical Ltd., a company that develops, manufactures, and markets non-invasive ambulatory diagnostic medical devices for sleep apnea and offers Total Sleep Solution using a cloud-based digital health platform, and SoClean Inc., a...
Itamar Medical Ltd., a company...
12/05/2019
EP Lab Digest
Press Release
12/03/2019
Impulse Dynamics, developer of Optimizer® Smart System for delivering CCM™ therapy, announced the completion of an $80.25 million Series D financing with new investors. The proceeds will be used primarily to facilitate U.S....
Impulse Dynamics, developer of Optimizer® Smart System for delivering CCM™ therapy, announced the completion of an $80.25 million Series D financing with new investors. The proceeds will be used primarily to facilitate U.S....
Impulse Dynamics, developer...
12/03/2019
EP Lab Digest
Press Release
12/03/2019
BioSig Technologies, Inc., a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intracardiac signals, announced that the Company...
BioSig Technologies, Inc., a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intracardiac signals, announced that the Company...
BioSig Technologies, Inc., a...
12/03/2019
EP Lab Digest
Press Release
11/25/2019
Chicago-based medical device firm Attune Medical’s ensoETM is being evaluated in numerous ongoing clinical studies to investigate device efficacy in reducing thermal injury to the esophagus during cardiac ablation procedures, a common...
Chicago-based medical device firm Attune Medical’s ensoETM is being evaluated in numerous ongoing clinical studies to investigate device efficacy in reducing thermal injury to the esophagus during cardiac ablation procedures, a common...
Chicago-based medical device...
11/25/2019
EP Lab Digest
Press Release
11/25/2019
Thrombosis Research Institute (TRI) has launched the GARFIELD-AF Risk Calculator, an innovative tool for aiding clinician decision making in treating patients with newly diagnosed atrial fibrillation (AF). The tool utilizes individual patient...
Thrombosis Research Institute (TRI) has launched the GARFIELD-AF Risk Calculator, an innovative tool for aiding clinician decision making in treating patients with newly diagnosed atrial fibrillation (AF). The tool utilizes individual patient...
Thrombosis Research Institute...
11/25/2019
EP Lab Digest